Blaze Bioscience Inc.   Report issue

For profit Phase 3
Founded: Seattle WA United States (2010)
Status: No NME R&D (2010)

Organization Overview

First Clinical Trial
2013
NCT02097875
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Blaze Bioscience Australia Pty Ltd | Blaze Bioscience Inc.